EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY 4.0

Extended follow-up outcomes of patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab on EMPOWER-CSCC-1: A retrospective cohort study

Catherine Bennett, Luke S McLean, Annette M Lim, Mathias Bressel, Alexander Guminski, Brett G M Hughes, Samantha E Bowyer, Brian Stein, Danny Rischin

Journal of the American Academy of Dermatology · 2026

DOI: 10.1016/j.jaad.2025.11.080 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of the American Academy of Dermatology, 2026. Verfasst von Catherine Bennett und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Skin Neoplasms, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Immunological. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Peter MacCallum Cancer Centre, NHMRC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellSkin NeoplasmsAntibodies, Monoclonal, HumanizedAntineoplastic Agents, ImmunologicalHumansMaleRetrospective StudiesFemaleAgedFollow-Up StudiesMiddle AgedAged, 80 and overProgression-Free SurvivalAustraliaRetreatmentTreatment Outcome

Stichwörter der Autor:innen

adultaged, 80 and overantibodies, monoclonal/therapeutic usecarcinoma, squamous cell/drug therapyfemalefollow-up studiesimmune checkpoint inhibitormaleprogrammed cell disease 1 receptor/antagonists and inhibitorsskin neoplasms/drug therapy

Substanzen

cemiplimabAntibodies, Monoclonal, HumanizedAntineoplastic Agents, Immunological

Autor:innen und Institutionen

  • Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia; Department of M…
  • Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
  • The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia; Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, New South Wales, Australia.
  • The University of Queensland, Brisbane, Queensland, Australia; Department of Medical Oncology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.

Förderung

  • Peter MacCallum Cancer Centre
  • NHMRC

Zitieren

APA

Bennett, C., McLean, L. S., Lim, A. M., Bressel, M., Guminski, A., Hughes, B. G. M., Bowyer, S. E., Stein, B., & Rischin, D. (2026). Extended follow-up outcomes of patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab on EMPOWER-CSCC-1: A retrospective cohort study. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2025.11.080

Vancouver

Bennett C, McLean LS, Lim AM, Bressel M, Guminski A, Hughes BGM, et al. Extended follow-up outcomes of patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab on EMPOWER-CSCC-1: A retrospective cohort study. Journal of the American Academy of Dermatology. 2026. doi:10.1016/j.jaad.2025.11.080

BibTeX
@article{Bennett2026,
  author = {Bennett, Catherine and McLean, Luke S and Lim, Annette M and Bressel, Mathias and Guminski, Alexander and Hughes, Brett G M and Bowyer, Samantha E and Stein, Brian and Rischin, Danny},
  title = {Extended follow-up outcomes of patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab on EMPOWER-CSCC-1: A retrospective cohort study},
  journal = {Journal of the American Academy of Dermatology},
  year = {2026},
  doi = {10.1016/j.jaad.2025.11.080}
}
Kostenlos starten →